Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.70 per share, payable on October 29, 2021, to shareholders of record as of September 30, 2021. This move underscores Humana's commitment to providing benefits to its investors while enhancing integrated care solutions aimed at improving health outcomes and lowering costs for its members.
Humana continues to support healthcare professionals with resources and tools, ensuring easier navigation through healthcare services.
Humana Inc. (NYSE: HUM) has completed its acquisition of Kindred at Home (KAH), enhancing its position as the largest provider of home healthcare in the U.S. KAH serves over 550,000 patients annually, and its integration into Humana's Home Solutions business aims to improve patient outcomes and satisfaction. The transition to the new CenterWell brand is set for 2022. This acquisition is expected to accelerate clinical innovation and enhance overall healthcare delivery, while also expanding Humana’s workforce with thousands of new caregivers.
Humana Inc. (NYSE: HUM) has released its 2020 Corporate Social Responsibility (CSR) report, highlighting its dedication to health equity and community needs. Amid the COVID-19 pandemic, the company launched new employee benefits, conducted over 6.2 million health screenings, and contributed $50 million in aid to underserved communities. Humana also achieved Energy Star certification for 22 sites, showcased its commitment to health equity by appointing new leadership, and emphasized transparency in its environmental, social, and governance practices moving forward.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $3.0 billion in senior notes, consisting of three tranches: $1.5 billion due 2023, $750 million due 2027, and $750 million due 2032. The expected net proceeds are approximately $2.973 billion. These funds will primarily support the $5.7 billion acquisition of Kindred at Home. If the acquisition is not finalized by January 22, 2022, the company will redeem the 2023 notes. The press release includes cautionary forward-looking statements regarding potential risks affecting business performance.
Humana Inc (NYSE: HUM) has appointed Sue Schick as President of its Group, Military, and Specialty businesses, effective September 1, 2021. Schick, who joined Humana in 2020 and has over 30 years of industry experience, succeeds Chris Hunter, who leaves to pursue other opportunities. Humana aims for ambitious growth in these segments. Currently, the Group, Military, and Specialty business serves 1.2 million employer group members and 12 million Commercial and Medicare Specialty members, while also administering the TRICARE health program for six million U.S. military beneficiaries.
Humana Inc. (NYSE: HUM) has announced a public offering of $3.0 billion in senior notes, comprising $1.5 billion of 0.650% notes due 2023, $750 million of 1.350% notes due 2027, and $750 million of 2.150% notes due 2032. The net proceeds, approximately $2.973 billion, will be used for the acquisition of Kindred at Home, which amounts to about $5.7 billion, inclusive of $1.9 billion in debt assumption. The offerings are scheduled to close on August 3, 2021, and are not conditioned on the acquisition's completion.
Summary not available.
Humana reported its 2Q21 results, with GAAP revenue at $20.645 billion, a year-over-year increase from $19.083 billion in 2Q20. However, GAAP pretax income dropped significantly from $2.586 billion in 2Q20 to $738 million in 2Q21. The diluted EPS fell to $4.55 from $13.75, while the non-GAAP adjusted EPS was $6.89, down from $12.56. Despite challenges from the ongoing pandemic, the company revised its FY2021 GAAP EPS guidance to $24.97-$25.47 and maintained its adjusted EPS guidance of $21.25-$21.75. A substantial gain from the acquisition of Kindred at Home is expected, estimated at $1 billion.
XSOLIS has partnered with Humana to implement a real-time predictive analytics platform aimed at enhancing utilization review processes. This collaboration will integrate XSOLIS' CORTEX platform, which analyzes patient data from electronic medical records to streamline interactions between payers and providers. The Precision Utilization Management initiative will allow for 'touchless' status determinations, freeing up clinician time for patient care. Both companies aim to revolutionize medical necessity determinations and improve healthcare efficiency.
The Humana Foundation is awarding $1.7 million to nonprofit organizations in Louisville through its Community Partners Program, aimed at enhancing health equity. Since 2018, the program has distributed over $8 million to local nonprofits tackling social determinants of health. The 2021 funding focuses on small, BIPOC-led organizations addressing issues like food security, education, and access to care. Organizations awarded funding range from $50,000 to $250,000, with a deadline for additional applications set for July 23.